PL354519A1 - Związki 1-cyklicznego amino-alkilocykloheksanu, ich kompozycje farmaceutyczne i ich zastosowanie jako środki przeciwdrgawkowe - Google Patents
Związki 1-cyklicznego amino-alkilocykloheksanu, ich kompozycje farmaceutyczne i ich zastosowanie jako środki przeciwdrgawkoweInfo
- Publication number
- PL354519A1 PL354519A1 PL99354519A PL35451999A PL354519A1 PL 354519 A1 PL354519 A1 PL 354519A1 PL 99354519 A PL99354519 A PL 99354519A PL 35451999 A PL35451999 A PL 35451999A PL 354519 A1 PL354519 A1 PL 354519A1
- Authority
- PL
- Poland
- Prior art keywords
- cyclic amino
- compounds
- pharmaceutical compositions
- alleviation
- alkyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000001961 anticonvulsive agent Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229940125681 anticonvulsant agent Drugs 0.000 title 1
- 206010010904 Convulsion Diseases 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 229940127351 Uncompetitive NMDA Receptor Antagonists Drugs 0.000 abstract 1
- 230000001773 anti-convulsant effect Effects 0.000 abstract 1
- 230000000573 anti-seizure effect Effects 0.000 abstract 1
- 229960003965 antiepileptics Drugs 0.000 abstract 1
- 230000036461 convulsion Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- -1 optical isomers Chemical class 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000024587 synaptic transmission, glutamatergic Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP1999/008317 WO2001032640A1 (en) | 1999-11-01 | 1999-11-01 | 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL354519A1 true PL354519A1 (pl) | 2004-01-26 |
| PL199587B1 PL199587B1 (pl) | 2008-10-31 |
Family
ID=8167482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL354519A PL199587B1 (pl) | 1999-11-01 | 1999-11-01 | Związek 1-cykliczny aminoalkilocykloheksanowy, sposób jego wytwarzania, kompozycja farmaceutyczna i zastosowanie związku 1-cyklicznego aminoalkilocykloheksanowego |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1228052B1 (pl) |
| JP (1) | JP4043236B2 (pl) |
| KR (1) | KR100548600B1 (pl) |
| CN (1) | CN1264827C (pl) |
| AT (1) | ATE361284T1 (pl) |
| AU (1) | AU782760B2 (pl) |
| CA (1) | CA2389325C (pl) |
| CY (1) | CY1106672T1 (pl) |
| CZ (1) | CZ20021533A3 (pl) |
| DE (1) | DE69936004T2 (pl) |
| DK (1) | DK1228052T3 (pl) |
| EA (1) | EA005684B1 (pl) |
| ES (1) | ES2285870T3 (pl) |
| HK (1) | HK1049160B (pl) |
| HU (1) | HUP0203275A3 (pl) |
| IL (2) | IL149401A0 (pl) |
| MX (1) | MXPA02004368A (pl) |
| NO (1) | NO322359B1 (pl) |
| PL (1) | PL199587B1 (pl) |
| PT (1) | PT1228052E (pl) |
| SI (1) | SI1228052T1 (pl) |
| TW (1) | TWI242547B (pl) |
| UA (1) | UA72558C2 (pl) |
| WO (1) | WO2001032640A1 (pl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
| US8278345B2 (en) | 2006-11-09 | 2012-10-02 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| ATE554085T1 (de) | 2006-11-30 | 2012-05-15 | Probiodrug Ag | Neue inhibitoren von glutaminylcyclase |
| JP5930573B2 (ja) | 2007-03-01 | 2016-06-15 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤の新規使用 |
| WO2008128985A1 (en) | 2007-04-18 | 2008-10-30 | Probiodrug Ag | Thiourea derivatives as glutaminyl cyclase inhibitors |
| PL2475428T3 (pl) | 2009-09-11 | 2015-12-31 | Probiodrug Ag | Pochodne heterocykliczne jako inhibitory cyklazy glutaminowej |
| ES2586231T3 (es) | 2010-03-03 | 2016-10-13 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
| MX2012010470A (es) | 2010-03-10 | 2012-10-09 | Probiodrug Ag | Inhibidores heterociclicos d ciclasa de glutaminilo (qc, ec .3 2. 5). |
| US8541596B2 (en) | 2010-04-21 | 2013-09-24 | Probiodrug Ag | Inhibitors |
| EP2686313B1 (en) | 2011-03-16 | 2016-02-03 | Probiodrug AG | Benzimidazole derivatives as inhibitors of glutaminyl cyclase |
| CN104211663B (zh) * | 2014-08-11 | 2017-01-11 | 杭州偶联医药科技有限公司 | 一种(s)-n-甲氧基-甲基-2-(四氢吡咯基)丙酰胺及其制备方法和应用 |
| PL3461819T3 (pl) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitory cyklazy glutaminylowej |
| RU2714135C1 (ru) * | 2019-11-22 | 2020-02-12 | Федеральное государственное бюджетное учреждение науки "Институт токсикологии Федерального медико-биологического агентства" | Гидрохлорид (1-метилпиперидин-4-ил)-2-пропилпентаноата, обладающий холинолитической и противосудорожной активностью |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3097207A (en) * | 1958-03-06 | 1963-07-09 | Parke Davis & Co | 1-halophenyl and 1-alkoxyphenyl cyclohexylamines |
| UA61962C2 (uk) * | 1997-06-30 | 2003-12-15 | Мерц Фарма Гмбх Унд Ко. Кгаа | Сполука 1-аміноалкілциклогексану, фармацевтична композиція на її основі та спосіб лікування |
-
1999
- 1999-01-11 UA UA2002054475A patent/UA72558C2/uk unknown
- 1999-11-01 CA CA002389325A patent/CA2389325C/en not_active Expired - Fee Related
- 1999-11-01 PL PL354519A patent/PL199587B1/pl not_active IP Right Cessation
- 1999-11-01 HK HK03101158.3A patent/HK1049160B/zh not_active IP Right Cessation
- 1999-11-01 AT AT99974146T patent/ATE361284T1/de not_active IP Right Cessation
- 1999-11-01 SI SI9930972T patent/SI1228052T1/sl unknown
- 1999-11-01 ES ES99974146T patent/ES2285870T3/es not_active Expired - Lifetime
- 1999-11-01 CN CNB998169900A patent/CN1264827C/zh not_active Expired - Fee Related
- 1999-11-01 JP JP2001534791A patent/JP4043236B2/ja not_active Expired - Fee Related
- 1999-11-01 MX MXPA02004368A patent/MXPA02004368A/es not_active IP Right Cessation
- 1999-11-01 CZ CZ20021533A patent/CZ20021533A3/cs unknown
- 1999-11-01 DK DK99974146T patent/DK1228052T3/da active
- 1999-11-01 DE DE69936004T patent/DE69936004T2/de not_active Expired - Fee Related
- 1999-11-01 HU HU0203275A patent/HUP0203275A3/hu unknown
- 1999-11-01 PT PT99974146T patent/PT1228052E/pt unknown
- 1999-11-01 KR KR1020027005621A patent/KR100548600B1/ko not_active Expired - Fee Related
- 1999-11-01 IL IL14940199A patent/IL149401A0/xx active IP Right Grant
- 1999-11-01 EP EP99974146A patent/EP1228052B1/en not_active Expired - Lifetime
- 1999-11-01 AU AU11585/00A patent/AU782760B2/en not_active Ceased
- 1999-11-01 WO PCT/EP1999/008317 patent/WO2001032640A1/en not_active Ceased
- 1999-11-01 EA EA200200522A patent/EA005684B1/ru not_active IP Right Cessation
- 1999-11-15 TW TW088119884A patent/TWI242547B/zh not_active IP Right Cessation
-
2002
- 2002-04-29 IL IL149401A patent/IL149401A/en not_active IP Right Cessation
- 2002-04-30 NO NO20022044A patent/NO322359B1/no not_active IP Right Cessation
-
2007
- 2007-06-21 CY CY20071100831T patent/CY1106672T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1106672T1 (el) | Ενωσεις 1-κυκλικου αμινο-αλκυλοκυκλοεξανιου, φαρμακευτικες συνθεσεις αυτων και η χρηση τους ως αντισπασμωδικα | |
| ITMI922006A1 (it) | Esteri nitrici di derivati dell'acido 2-(2, 6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione | |
| EP1361220A4 (en) | CYCLIC COMPOUNDS WITH THROMBOPOIETIN RECEPTAGONISM | |
| PT96001A (pt) | Processo para a preparacao de derivados de isoquinolina condensada com um anel carbociclico | |
| EP1036794A4 (en) | 2-ARYL-8-OXODIHYDROPURIN DERIVATIVES, THEIR PRODUCTION, THEIR USE AS MEDICINE COMPONENTS AND THEIR INTERMEDIATES | |
| EP1207155A4 (en) | DRUG COMPOSITIONS HAVING AGONIST THROMBOPOIETINE ACTIVITY | |
| MXPA04001258A (es) | Activador para el receptor d que responde al proliferador de peroxisoma. | |
| MXPA04003398A (es) | Activador para el receptor o activado con el proliferador de peroxisoma. | |
| AU2337197A (en) | Cinnamic acid derivatives and their use as integrin antagonists | |
| IL133623A0 (en) | Antithrombotic agents | |
| MX9801716A (es) | Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina. | |
| EP0999834A4 (en) | ANTITHROMOSIS | |
| DE69528257D1 (de) | KONDENSIERTE HETEROCYCLISCHE VERBINDUNG, DEREN HERSTELLUNG UND VERWENDUNG ALS GnRH ANTAGONISTEN | |
| AU2267495A (en) | Benzamide derivatives as vasopressin antagonists | |
| HUT65351A (en) | Process for preparing ethanolamine derivatives haring sympathominetic and anti-pollakiuria activity and pharmaceutical compositions containing them as active agent | |
| AU672052B2 (en) | Antidepressant and antiparkinsonian compounds | |
| SI1233953T1 (en) | Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same | |
| CA2226886A1 (en) | N-(4-substituted-benzyl)-2-aminolactam derivatives | |
| AU3191293A (en) | New naphthalene amides and sulphonamides, processes for their preparation and pharmaceutical compositions containing them | |
| CR20230218A (es) | Nuevos derivados de indazol acetileno | |
| TR200002808T2 (tr) | İlaç olarak yararlı C11 oksimil ve hidroksilamino prostaglandinleri | |
| MX9600816A (es) | Nuevos derivados triciclicos, su preparacion, su aplicacion a la preparacion de la colquicina y de la tiocolquicina, opticamente activas o racemicas, y de compuestos analogos o derivados e intermedios. | |
| FI945582A0 (fi) | Substituoidut (aryylialkyyliaminobentsyyli) aminopropioniamidijohdannaiset, niiden valmistus ja käyttö anti-epileptisinä, neuroprotektiivisina ja antidepressiivisina aineina | |
| HUT61018A (en) | Process for producing 3-/1-thiazolidinylbutyl-4-piperazinyl/1-h-indazole derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| HUT60491A (en) | Process for producing substituted n-benzylindole derivatives having leukotriene antagonist effect and pharmaceutical compositions comprising such compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Decisions on the lapse of the protection rights |
Effective date: 20091101 |